BVD 10

BVD 10, a neuropeptide Y (NPY) analogue peptide, is a highly selective NPY Y1 receptor antagonist. BVD10 significantly prevents NPY-induced glutamate increase. BVD 10 can be used for seizure research[1].

Product Specifications

CAS Number

[262418-00-8]

UNSPSC

12352209

Target

Neuropeptide Y Receptor

Related Pathways

GPCR/G Protein; Neuronal Signaling

Field of Research

Neurological Disease

Smiles

OC(C=C1)=CC=C1C[C@@H](C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(N)=N)C(N[C@H](C(OC)=O)CC2=CC=C(C=C2)O)=O)=O)=O)=O)NC([C@H]([C@@H](C)CC)NC([C@H]3N(CCC3)C([C@H](CC(N)=O)NC([C@@H](N)[C@@H](C)CC)=O)=O)=O)=O

Molecular Formula

C58H92N16O13

Molecular Weight

1221.45

References & Citations

[1]Meurs A, et al. Neuropeptide Y increases in vivo hippocampal extracellular glutamate levels through Y1 receptor activation. Neurosci Lett. 2012 Feb 29;510 (2) :143-7.